Unveiling the ageing-related genes in diagnosing osteoarthritis with metabolic syndrome by integrated bioinformatics analysis and machine learning
Clinical Snapshot
PICO Framework
| P — Population | Patients with osteoarthritis and metabolic syndrome (from public databases) |
| I — Intervention | Machine learning-based diagnostic model using 5 ageing-related genes (CEBPB, PTEN, ARPC1B, PIK3R1, CDC42) |
| C — Comparator | Four different machine learning algorithms (RF, SVM, GLM, XGB) compared for diagnostic accuracy |
| O — Outcomes | Diagnostic accuracy measured by ROC curves, nomogram performance, and correlation with immune cell infiltration |
Bottom Line
This bioinformatics study identified a 5-gene machine learning model for diagnosing osteoarthritis patients with metabolic syndrome. While the methodology is sophisticated, combining multiple databases and machine learning approaches, the clinical utility remains questionable. The study lacks independent validation, uses retrospective database samples that may not represent real clinical populations, and requires specialized gene expression testing not routinely available. The reference standard for combined OA-MetS diagnosis is unclear, and there's no evidence this approach would change patient management. Australian clinicians should be cautious about the clinical applicability, as the required genetic testing infrastructure is not widely available and would not be Medicare-funded for this indication. This represents early-stage biomarker research that requires substantial validation before clinical implementation.
Key Findings
P Value: Not specified in abstract
Effect Size: SVM model selected as best performing among 4 algorithms tested
Primary Outcome: 5-gene SVM diagnostic model for OA patients with metabolic syndrome
Nnt Or Sensitivity: ROC curve analysis performed but specific sensitivity/specificity values not provided
Confidence Interval: Not reported in abstract
Clinical Application
Low - requires specialized gene expression analysis not available in routine clinical practice Limited applicability in Australian primary care; would require specialized pathology services not covered by Medicare for routine screening Patients suspected of having both osteoarthritis and metabolic syndrome
Abstract
Ageing significantly contributes to osteoarthritis (OA) and metabolic syndrome (MetS) pathogenesis, yet the underlying mechanisms remain unknown. This study aimed to identify ageing-related biomarkers in OA patients with MetS. OA and MetS datasets and ageing-related genes (ARGs) were retrieved from public databases. The limma package was used to identify differentially expressed genes (DEGs), and weighted gene coexpression network analysis (WGCNA) screened gene modules, and machine learning algorithms, such as random forest (RF), support vector machine (SVM), generalised linear model (GLM), and extreme gradient boosting (XGB), were employed. The nomogram and receiver operating characteristic (ROC) curve assess the diagnostic value, and CIBERSORT analysed immune cell infiltration. We identified 20 intersecting genes among DEGs of OA, key module genes of MetS, and ARGs. By comparing the accuracy of the four machine learning models for disease prediction, the SVM model, which includes CEBPB, PTEN, ARPC1B, PIK3R1, and CDC42, was selected. These hub ARGs not only demonstrated strong diagnostic values based on nomogram data but also exhibited a significant correlation with immune cell infiltration. Building on these findings, we have identified five hub ARGs that are associated with immune cell infiltration and have constructed a nomogram aimed at early diagnosing OA patients with MetS.
References
- 1.Huang, J., Wang, L., Zhou, J., Dai, T., Zhu, W., Wang, T., Wang, H., & Zhang, Y. (2025). Unveiling the ageing-related genes in diagnosing osteoarthritis with metabolic syndrome by integrated bioinformatics analysis and machine learning. Artificial Cells, Nanomedicine, and Biotechnology, 53(1). https://doi.org/10.1080/21691401.2025.2471762
Related Research
The Journal of rheumatology
Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review
3 Aug 2026
Rheumatic diseases clinics of North America
Demystifying Artificial Intelligence: Key Concepts with Examples in Rheumatology
2 Aug 2026
Rheumatic diseases clinics of North America
Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service